News
Mark Goodridge will retire as chair in October, and Gary Shaughnessy has been elected as his successor
Researchers have shown that boosting levels of oestrogen in the brains of mice improved symptoms by slowing the build-up of the toxic protein alpha-synuclein.
Researchers have shown that an ‘easy to use’ portable stimulation headset may be able to reduce both motor and non-motor symptoms of Parkinson’s.
A new report from the Disability Benefits Consortium shows how changes to the benefits system have had a devastating impact on disabled people.
In a seminal research paper, published in Lancet Neurology, researchers from King’s College London have used brain scans to uncover early changes in the brain that may happen years before the symptoms of Parkinson's appear.
Researchers in the US have identified a protein in the brain that may reduce the spread of the toxic alpha-synuclein protein in Parkinson's.
Researchers at King's College London have investigated the properties of over 1,000 approved drugs to identify 2 with potential for Parkinson's.
The results indicate that, when given early, the molecule Anle138b may restore dopamine levels and help slow or stop Parkinson’s in its tracks.
Researchers in the US have launched a clinical trial to test a drug with the potential to slow the progression of Lewy body dementia.
Our values shape the new volunteer awards, so we take a look at some of the volunteers showcasing them.